BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15703817)

  • 1. Spectral karyotyping of sarcomas and fibroblasts derived from Ink4a/Arf-deficient mice reveals chromosomal instability in vitro.
    Robertson SA; Schoumans J; Looyenga BD; Yuhas JA; Zylstra CR; Koeman JM; Swiatek PJ; Teh BT; Williams BO
    Int J Oncol; 2005 Mar; 26(3):629-34. PubMed ID: 15703817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
    Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
    Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice.
    Wang Y; Zhang Z; Kastens E; Lubet RA; You M
    Cancer Res; 2003 Aug; 63(15):4389-95. PubMed ID: 12907609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging.
    Matheu A; Pantoja C; Efeyan A; Criado LM; Martín-Caballero J; Flores JM; Klatt P; Serrano M
    Genes Dev; 2004 Nov; 18(22):2736-46. PubMed ID: 15520276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal instability and phenotypic plasticity during the squamous-spindle carcinoma transition: association of a specific T(14;15) with malignant progression.
    Pons M; Cigudosa JC; Rodríguez-Perales S; Bella JL; González C; Gamallo C; Quintanilla M
    Oncogene; 2005 Nov; 24(51):7608-18. PubMed ID: 16007119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different cooperating effect of p21 or p27 deficiency in combination with INK4a/ARF deletion in mice.
    Martín-Caballero J; Flores JM; García-Palencia P; Collado M; Serrano M
    Oncogene; 2004 Oct; 23(50):8231-7. PubMed ID: 15378017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of Arf causes tumor progression of PDGFB-induced oligodendroglioma.
    Tchougounova E; Kastemar M; Bråsäter D; Holland EC; Westermark B; Uhrbom L
    Oncogene; 2007 Sep; 26(43):6289-96. PubMed ID: 17438529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis.
    Uhrbom L; Kastemar M; Johansson FK; Westermark B; Holland EC
    Cancer Res; 2005 Mar; 65(6):2065-9. PubMed ID: 15781613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. INK4a/Arf is required for suppression of EGFR/DeltaEGFR(2-7)-dependent ERK activation in mouse astrocytes and glioma.
    Lachat Y; Diserens AC; Nozaki M; Kobayashi H; Hamou MF; Godard S; De Tribolet N; Hegi ME
    Oncogene; 2004 Sep; 23(41):6854-63. PubMed ID: 15273738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice.
    Harvey M; Sands AT; Weiss RS; Hegi ME; Wiseman RW; Pantazis P; Giovanella BC; Tainsky MA; Bradley A; Donehower LA
    Oncogene; 1993 Sep; 8(9):2457-67. PubMed ID: 8103211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential roles of p16INK4A and p14ARF genes in prognosis of oral carcinoma.
    Sailasree R; Abhilash A; Sathyan KM; Nalinakumari KR; Thomas S; Kannan S
    Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):414-20. PubMed ID: 18268126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic malignancies associated with increased Stat5 and Bcl-x(L) expressions in Ink4a/Arf-deficient mice.
    Sung YH; Park J; Choi B; Kim J; Cheong C; Choi YS; Yang EY; Lee M; Han JS; Park SC; Han TH; Kim TJ; Song J; Rhee K; Lee HW
    Mech Ageing Dev; 2005; 126(6-7):732-9. PubMed ID: 15888328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of nevi and skin tumors in Ink4a/Arf Xpa knockout mice by neonatal, intermittent, or chronic UVB exposures.
    van Schanke A; van Venrooij GM; Jongsma MJ; Banus HA; Mullenders LH; van Kranen HJ; de Gruijl FR
    Cancer Res; 2006 Mar; 66(5):2608-15. PubMed ID: 16510579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma.
    Chinnasri P; Pairojkul C; Jearanaikoon P; Sripa B; Bhudhisawasdi V; Tantimavanich S; Limpaiboon T
    Hum Pathol; 2009 Jun; 40(6):817-26. PubMed ID: 19200577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homozygous deletions of the INK4a/ARF locus in renal cell cancer.
    Kasahara T; Bilim V; Hara N; Takahashi K; Tomita Y
    Anticancer Res; 2006; 26(6B):4299-305. PubMed ID: 17201148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ink4a/Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse.
    Khoo CM; Carrasco DR; Bosenberg MW; Paik JH; Depinho RA
    Proc Natl Acad Sci U S A; 2007 Mar; 104(10):3931-6. PubMed ID: 17360455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer.
    Kawamoto K; Enokida H; Gotanda T; Kubo H; Nishiyama K; Kawahara M; Nakagawa M
    Biochem Biophys Res Commun; 2006 Jan; 339(3):790-6. PubMed ID: 16316628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
    Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 Deficiency leads to compensatory up-regulation of p16INK4a.
    Leong WF; Chau JF; Li B
    Mol Cancer Res; 2009 Mar; 7(3):354-60. PubMed ID: 19240179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.